Sherri Sheinfeld Gorin

Dr. Sherri Sheinfeld Gorin

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2017 in Annals of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
SGSherri Sheinfeld Gorin
Sherri Sheinfeld Gorin
DHDavid Haggstrom
David Haggstrom
PHPaul K. J. Han
Paul K. J. Han
KFKathleen M. Fairfield
Kathleen M. Fairfield
PKPaul Krebs
Paul Krebs
SCSteven B. Clauser
Steven B. Clauser
Background. According to a landmark study by the Institute of Medicine, patients with cancer often receive poorly coordinated care in multiple settings

1 October 2016 in The American Journal of Medicine
Verified
Journal Article
Closed access
MAMona AuYoung
Mona AuYoung
SLSarah E. Linke
Sarah E. Linke
SPSherry Pagoto
Sherry Pagoto
MBMatthew Buman
Matthew Buman
LCLynette L. Craft
Lynette L. Craft
SGSherri Sheinfeld Gorin
Sherri Sheinfeld Gorin

1 May 2012 in JNCI Monographs
Verified
Journal Article
Open access
PDF file
SGSherri Sheinfeld Gorin
Sherri Sheinfeld Gorin
HBHoda Badr
Hoda Badr
PKPaul Krebs
Paul Krebs
IDIrene Prabhu Das
Irene Prabhu Das
To examine the impact of multilevel interventions (with three or more levels of influence) designed to reduce health disparities, we conducted a systematic review and meta-analysis of interventions for ethnic/racial minorities (all except non-Hispanic whites) that were published between January 2000 and July 2011. The primary aims were to synthesize the findings of studies evaluating multilevel interventions (three or more levels of influence) targeted at ethnic and racial minorities to reduce disparities in their health care and obtain a quantitative estimate of the effect of multilevel interventions on health outcomes among these subgroups. The electronic database PubMed was searched using Medical Subject Heading terms and key words. After initial review of abstracts, 26 published studies were systematically reviewed by at least two independent coders. Those with sufficient data (n = 12) were assessed by meta-analysis and examined for quality using a modified nine-item Physiotherapy Evidence Database coding scheme. The findings from this descriptive review suggest that multilevel interventions have positive effects on several health behavior outcomes, including cancer prevention and screening, as well improving the quality of health-care system processes. The weighted average effect size across studies for all health behavior outcomes reported at the individual participant level (k = 17) was odds ratio (OR) = 1.27 (95% confidence interval [CI] = 1.11 to 1.44); for the outcomes reported by providers or organizations, the weighted average effect size (k = 3) was OR = 2.53 (95% CI = 0.82 to 7.81). Enhanced application of theories to multiple levels of change, novel design approaches, and use of cultural leveraging in intervention design and implementation are proposed for this nascent field.

25 June 2013 in Implementation Science
Verified
Journal Article
Open access
PDF file
TGThe MOHR Study Group
The MOHR Study Group
AKAlex H Krist
Alex H Krist
BGBeth A Glenn
Beth A Glenn
RGRussell E Glasgow
Russell E Glasgow
BBBijal A Balasubramanian
Bijal A Balasubramanian
KSKurt C Stange
Kurt C Stange
There is a pressing need for greater attention to patient-centered health behavior and psychosocial issues in primary care, and for practical tools, study designs and results of clinical and policy relevance. Our goal is to design a scientifically rigorous and valid pragmatic trial to test whether primary care practices can systematically implement the collection of patient-reported information and provide patients needed advice, goal setting, and counseling in response.

17 June 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
JSJovana Stojanovic
Jovana Stojanovic
VBVincent Gosselin Boucher
Vincent Gosselin Boucher
MGMyriam Gagne
Myriam Gagne
SGSamir Gupta
Samir Gupta
JKJoyal-Desmarais Keven
Joyal-Desmarais Keven
KLKim L Lavoie
Kim L Lavoie
The success of large-scale COVID-19 vaccination campaigns is contingent upon people being willing to receive the vaccine. Our study explored COVID-19 vaccine hesitancy and its correlates in eight different countries around the globe. We analyzed convenience sample data collected between March 2020 and January 2021 as part of the iCARE cross-sectional study. Univariate and multivariate statistical analyses were conducted to explore the correlates of vaccine hesitancy. We included 32,028 participants from eight countries, and observed that 27% of the participants exhibited vaccine hesitancy, with increases over time. France reported the highest level of hesitancy (47.3%) and Brazil reported the lowest (9.6%). Women, younger individuals (≤29 years), people living in rural areas, and those with a lower perceived income were more likely to be hesitant. People who previously received an influenza vaccine were 70% less likely to report COVID-19 vaccine hesitancy. We observed that people reporting greater COVID-19 health concerns were less likely to be hesitant, whereas people with higher personal financial concerns were more likely to be hesitant. Our findings indicate that there is substantial vaccine hesitancy in several countries, with cross-national differences in the magnitude and direction of the trend. Vaccination communication initiatives should target hesitant individuals (women, younger adults, people with lower incomes and those living in rural areas), and should highlight the immediate health, social and economic benefits of vaccination across these settings. Country-level analyses are warranted to understand the complex psychological, socio-environmental, and cultural factors associated with vaccine hesitancy.

10 November 2020 in Cancer
Verified
Journal Article
Open access
PDF file
SGSherri Sheinfeld Gorin
Sherri Sheinfeld Gorin
MJMasahito Jimbo
Masahito Jimbo
RHRobert Heizelman
Robert Heizelman
KHKathryn M. Harmes
Kathryn M. Harmes
DHDiane M. Harper
Diane M. Harper
Lay Summary: During the coronavirus disease 2019 (COVID‐19) pandemic, cancer screening decreased precipitously; home screening for colorectal cancer diminished less than that for colonoscopy and breast and cervical cancer screening. The authors have highlighted approaches for home cancer screening in addition to telemedicine.